IE33603B1 - Vaccines - Google Patents
VaccinesInfo
- Publication number
- IE33603B1 IE33603B1 IE143069A IE143069A IE33603B1 IE 33603 B1 IE33603 B1 IE 33603B1 IE 143069 A IE143069 A IE 143069A IE 143069 A IE143069 A IE 143069A IE 33603 B1 IE33603 B1 IE 33603B1
- Authority
- IE
- Ireland
- Prior art keywords
- allergenic material
- haloformate
- oct
- chloroformate
- allergenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1,243,832. Allergens. BEECHAM GROUP Ltd. 23 Oct., 1969 [25 Oct., 1968], No. 50645/ 68. Heading A5B. The allergenicity of an allergenic material is reduced by treating the allergenic material with a haloformate having the formula RO.CO.X wherein X is a halogen and R is alkyl, alkenyl, aryl, aralkyl, arylcarbonyl or a heterocyclic group, at a pH of from 1 to 7 and recovering the resultant modified allergenic material. The haloformate is preferably a chloroformate especially methyl, ethyl or benzoyl chloroformate. The temperature employed for the treatment is preferably about 20C. The allergenic material treated may be a protein or glycoprotein extract of the whole allergen. The allergenic material may be, or may be derived from, pollen. Pharmaceutical preparations for parenteral administration comprise the modified allergenic material and a parenterally acceptable carrier.
[GB1243832A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5064568A GB1243832A (en) | 1968-10-25 | 1968-10-25 | Vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
IE33603L IE33603L (en) | 1970-04-25 |
IE33603B1 true IE33603B1 (en) | 1974-08-21 |
Family
ID=10456759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE143069A IE33603B1 (en) | 1968-10-25 | 1969-10-20 | Vaccines |
Country Status (10)
Country | Link |
---|---|
AT (1) | AT293617B (en) |
BE (1) | BE740801A (en) |
CH (1) | CH536633A (en) |
DE (1) | DE1953995A1 (en) |
DK (1) | DK125308B (en) |
ES (1) | ES372843A1 (en) |
FR (1) | FR2021556B1 (en) |
GB (1) | GB1243832A (en) |
IE (1) | IE33603B1 (en) |
NL (1) | NL6916121A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2178582B1 (en) * | 2000-12-01 | 2003-11-01 | Lozano Juan Jose Martin | CUP PROFILE, FOR THE ASSEMBLY OF TWO FLOORS OF ELECTRIC PANELS. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1174854A (en) * | 1967-07-07 | 1969-12-17 | Miles Lab | New Biologically Active Conjugates |
-
1968
- 1968-10-25 GB GB5064568A patent/GB1243832A/en not_active Expired
-
1969
- 1969-10-20 IE IE143069A patent/IE33603B1/en unknown
- 1969-10-23 FR FR6936324A patent/FR2021556B1/fr not_active Expired
- 1969-10-23 DK DK561269A patent/DK125308B/en unknown
- 1969-10-24 ES ES372843A patent/ES372843A1/en not_active Expired
- 1969-10-24 AT AT1003869A patent/AT293617B/en not_active IP Right Cessation
- 1969-10-24 BE BE740801D patent/BE740801A/xx unknown
- 1969-10-24 NL NL6916121A patent/NL6916121A/xx unknown
- 1969-10-25 CH CH1589469A patent/CH536633A/en not_active IP Right Cessation
- 1969-10-27 DE DE19691953995 patent/DE1953995A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB1243832A (en) | 1971-08-25 |
NL6916121A (en) | 1970-04-28 |
FR2021556A1 (en) | 1970-07-24 |
AT293617B (en) | 1971-10-25 |
BE740801A (en) | 1970-04-24 |
DE1953995A1 (en) | 1970-04-30 |
CH536633A (en) | 1973-05-15 |
FR2021556B1 (en) | 1973-01-12 |
IE33603L (en) | 1970-04-25 |
ES372843A1 (en) | 1971-11-01 |
DK125308B (en) | 1973-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7800767A (en) | ADDITIONAL CONNECTION OF DIPEPTIDE DERIVATIVE AND AMINO ACID DERIVATIVE AS WELL AS THE PROCEDURE FOR PREPARING THIS. | |
NL181628C (en) | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH PROSTAGLANDINE-LIKE ACTION, AND METHOD FOR PREPARING 9-ALFA, 11-ALFA, 15-ALFA-TRIHYDROXY-PROSTA-4,5,13-TRI-ACID DERIVATIVES, PREVIOUSLY USED | |
EP0726758A4 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
IE35642B1 (en) | A process for the preparation of new alpha-aminopenicillins and such penicillins and intermediates and pharmaceutical preparations | |
NL7607649A (en) | PROCESS FOR PREPARING N- (3-TRIFLUORM-THYL 4-HALOGENOPHENYL) N'-BENZOYLUREA, AND PROCESS FOR PREPARING INSECTICIDE PREPARATIONS ON THE BASIS AND THEIR USE OF THEIR INJECTORS. | |
EP0342860A3 (en) | Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use | |
OA09889A (en) | Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus. | |
GB1183506A (en) | New vaccines for combating influenza and the preparation thereof | |
ATE182271T1 (en) | MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES | |
ATE99953T1 (en) | COMBINATION ANTIVIRAL MEDICATION. | |
NZ221379A (en) | Nematode plasma membrane-associated protein, extraction method and vaccines containing it | |
DE3751772D1 (en) | Vaccine for the treatment of HSV | |
IE33603B1 (en) | Vaccines | |
NL7803030A (en) | NEW ESTERS OF AMINO ACIDS AND NEW INTERMEDIATE PRODUCTS THEREOF, AND PROCEDURES FOR PREPARING AND USING THESE COMPOUNDS. | |
NL169337C (en) | PROCESS FOR THE PREPARATION OF FORMULAS OF MACROMOLECULAR THERMOPLASTIC POLYCARBONATES, AND PREPARED PREPARATIONS THEREOF. | |
EP0299050A4 (en) | Isolation of single chain proteins with fsh suppressing activity from follicular fluid. | |
Itil | Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients. | |
GB1114683A (en) | Process for purifying proteinaceous fractions from mistletoe by ultracentrifugation | |
IE32044L (en) | Tetanus vaccine | |
NL7609794A (en) | TRIFLUORMETHYL CONTAINING ARALKYL ESTERS OF AMINO ACIDS, PHARMACEUTICAL PREPARATION AND METHODS FOR PREPARING THEM | |
DE3781049D1 (en) | METHOD FOR PRODUCING HEPATITIS B VIRUS INTERNAL BODY IMPERANTIGENS (HBCAG) IN YEAST. | |
NL8001205A (en) | SPECTINOMYCIN ANALOGA, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL PREPARATIONS PREPARED THEREFROM. | |
NL7510068A (en) | PROCEDURE FOR PREPARING ESTERS OF 5-N-BUTYL-PYRIDINECARBONIC ACID- (2), PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SUCH AS FORMED. | |
GB1434181A (en) | Vaccine for the prevention and treatment of vascular conditions | |
GB1108245A (en) | A diuretic antitoxic and mental-stimulating extract of mammalian brain and a process for its production |